GeoVax Labs Inc
Filed Sep 6, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Sep 6, 2024
Contents
CAPITALIZATION
The following table sets forth our capitalization as of June 30, 2024:
| ● | on an actual basis; and |
| ● | on an as adjusted basis to give effect to (i) the issuance and sale by us of 975,310 shares of Common Stock in the Aug 28 Registered Direct Offering (inclusive of 138,110 shares of Common Stock issuable upon the exercise of pre-funded warrants), (ii) receipt of the gross proceeds from the Aug 28 Registered Direct Offering after deducting commissions and offering expenses payable by us, and (iii) the issuance of 975,610 shares of Common Stock issuable upon the exercise of the Aug 30 Common Warrant at a price of $5.00 per share. |
You should read this table together with our financial statements and the related notes, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
| As of June 30, 2024 (unaudited) | ||
|---|---|---|
| Actual | As Adjusted | |
| Cash and cash equivalents | $1,561,712 | $11,439,763 |
| Total liabilities | 6,404,296 | 6,404,296 |
| Stockholder’s equity: | ||
| Common Stock | 4,179 | 6,130 |
| Additional paid-in capital | 112,964,554 | 122,840,654 |
| Accumulated deficit | (115,277,959) | (115,277,959) |
| Total stockholders’ equity (deficiency) | $(2,309,226) | $13,973,121 |
The table and discussion above are based on 4,178,700 shares of Common Stock outstanding as of June 30, 2024, and 6,129,920 shares as adjusted as of that date, and do not include:
| ● | 5,642,137 shares of Common Stock issuable upon the exercise of other outstanding warrants with a weighted average exercise price of $5.44 per share |
|---|---|
| ● | 333,648 shares of Common Stock which are reserved for issuance under our 2020 and 2023 Stock Incentive Plans, of which 328,648 shares of Common Stock are issuable upon exercise of outstanding options at an average exercise price of $12.83 per share. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.